T-Cell and B-Cell Signaling Biomarkers and Treatment Targets in Lupus

Current Opinion in Rheumatology - United States
doi 10.1097/bor.0b013e32832e977c
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

T Cell Metabolism in Lupus

Immunometabolism
2020English

B Cell Tolerance and Positive Selection in Lupus

Journal of Immunology
AllergyImmunology
2012English

BCMA and Autoantibody-Producing RP105 B Cells ; Possible New Targets of B Cell Therapy in Systemic Lupus Erythematosus

Japanese Journal of Clinical Immunology
2012English

Missing-in-Metastasis/Metastasis Suppressor 1 Regulates B Cell Receptor Signaling, B Cell Metabolic Potential, and T Cell-Independent Immune Responses

Frontiers in Immunology
AllergyImmunology
2020English

Hormone Signaling Pathways as Treatment Targets in Renal Cell Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2016English

Engaging Novel Cell Types, Protein Targets and Efficacy Biomarkers in the Treatment of Diabetic Nephropathy

Frontiers in Pharmacology
Pharmacology
2014English

Cutting Edge: IFN- R Signaling in Non-T Cell Targets Regulates T Cell-Mediated Intestinal Inflammation Through Multiple Mechanisms

Journal of Immunology
AllergyImmunology
2014English

Oxidative Stress, T Cell DNA Methylation, and Lupus

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2014English

Transmembrane Signaling and T-Cell Immunodeficiency

Pediatric Research
Child HealthPediatricsPerinatology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy